Crystal Structure of the NUAK1-MARK3 kinase domain chimera bound with small molecule inhibitor N-(5-((5-chloro-4-(((3aS,6R,6aR)-6-methoxy-3a,5,6,6a-tetrahydrofuro[3,2-b]furan-3-yl)oxy)pyrimidin-2-yl)amino)-2-(((2R,7aR)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)phenyl)-1-methyl-1H-pyrazole-4-carboxamide
External Resource: Annotation
Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage
InterPro: Protein Family Classification InterPro Database Homepage
| Chains | Accession | Name | Type |
|---|---|---|---|
| IPR017441 | Protein kinase, ATP binding site | Binding Site | |
| IPR001772 | Kinase associated domain 1 (KA1) | Domain | |
| IPR000719 | Protein kinase domain | Domain | |
| IPR015940 | Ubiquitin-associated domain | Domain | |
| IPR028375 | KA1 domain/Ssp2, C-terminal | Homologous Superfamily | |
| IPR049508 | Serine/threonine-protein kinase MARK 1-4, catalytic domain | Domain | |
| IPR011009 | Protein kinase-like domain superfamily | Homologous Superfamily | |
| IPR008271 | Serine/threonine-protein kinase, active site | Active Site |
Pharos: Disease Associations Pharos Homepage Annotation
| Chains | Drug Target   | Associated Disease |
|---|---|---|
| :  P27448 |














